Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

AI reveals new class of cellular 'off switch' linked to cancer pathways

9 September 2026 · By · Wire by Fusion42

Published

9 September 2026

Topic

opportunities

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at news.cornell.edu →

◆ Verified

Fusion42 · 10 September 2026 · Fusion42 review

Cornell researchers used AI to identify a new class of cellular 'off switch' proteins, including Avl9, that regulate Arf1 activity, influencing intracellular transport and cancer cell movement.

This Wire brief sits within Fusion42's coverage of Biotech.

◆ ◆ The Wire takeaway

You can accelerate drug discovery by focusing on these newly identified 'off switch' proteins that regulate cancer cell behavior. This AI-driven insight opens doors to novel targets previously overlooked in cellular transport regulation.

◆ Coverage

1 source · 9 Sep 2026

◆ Related on Wire

◆ Topics

Biotechai-discoverycell-biologyprotein-regulationcancer-pathwaysdenn-domain-proteins